SCHEMBL20985641

SCHEMBL20985641

CSc1nc(-c2ccc(C#C[Si](C)(C)C)cc2)cc(C(F)(F)F)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
L3MBTL1 Q9Y468 4/20 0.41
TP53 P04637 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
ALDH1A1 P00352 5/20 0.41
NPSR1 Q6W5P4 4/20 0.41
MAPK1 P28482 3/20 0.41
HSD17B10 Q99714 3/20 0.41
HPGD P15428 2/20 0.41
MAPT P10636 3/20 0.40
KDM4E B2RXH2 5/20 0.39
LMNA P02545 2/20 0.38
RAB9A P51151 2/20 0.38
SDHB P21912 1/20 0.38
PTGS2 P35354 1/20 0.38
MITF O75030 1/20 0.38
STAT3 P40763 1/20 0.38
STAT1 P42224 1/20 0.38
TLR9 Q9NR96 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29976132 1.00 MEN1 (0.43) MEN1KMT2AL3MBTL1TP53SMN1; SMN2
SCHEMBL19805931 0.83 MEN1 (0.45) MEN1KMT2AL3MBTL1TP53SMN1; SMN2
SCHEMBL20985691 0.83 MEN1 (0.45) MEN1KMT2AL3MBTL1TP53SMN1; SMN2
SCHEMBL19806054 0.79 KDM4E (0.60) MEN1KMT2AL3MBTL1TP53SMN1; SMN2
SCHEMBL4718764 0.79 MEN1 (0.49) MEN1KMT2AL3MBTL1TP53SMN1; SMN2
SCHEMBL19805930 0.79 SDHB (0.57) MEN1KMT2AL3MBTL1TP53SMN1; SMN2
SCHEMBL20985669 0.78 KDM4E (0.61) MEN1KMT2AL3MBTL1TP53SMN1; SMN2
SCHEMBL19805780 0.76 KDM4E (0.66) MEN1KMT2ATP53SMN1; SMN2ALDH1A1
SCHEMBL20985731 0.74 MEN1 (0.63) MEN1KMT2AL3MBTL1TP53SMN1; SMN2
SCHEMBL1257981 0.73 MAPT (0.53) MEN1KMT2AL3MBTL1TP53SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11725000-B2 Apoptosis inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2023-08-15 US disclosed
US-11725000-B2 Apoptosis inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2023-08-15 US disclosed
US-11725000-B2 Apoptosis inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2023-08-15 US disclosed
US-20210309647-A1 Apoptosis Inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2021-10-07 US disclosed
US-20210309647-A1 Apoptosis Inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2021-10-07 US disclosed
US-11034680-B2 Apoptosis inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2021-06-15 US disclosed
US-11034680-B2 Apoptosis inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2021-06-15 US disclosed
EP-3484854-B1 APOPTOSIS INHIBITORS NAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING (CN) 2021-01-20 EP disclosed
US-20190152960-A1 Apoptosis Inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2019-05-23 US disclosed
US-20190152960-A1 Apoptosis Inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2019-05-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190152960-A1 Apoptosis Inhibitors BAX, SDHA, SDHB MEN1 4080/4885KMT2A 3060/4885L3MBTL1 1858/4885
US-11725000-B2 Apoptosis inhibitors BAX, SDHA, SDHB MEN1 4080/4885KMT2A 3060/4885L3MBTL1 1858/4885
US-11034680-B2 Apoptosis inhibitors BAX, SDHA, SDHB MEN1 4080/4885KMT2A 3060/4885L3MBTL1 1858/4885
US-20210309647-A1 Apoptosis Inhibitors BAX, SDHA, SDHB MEN1 4080/4885KMT2A 3060/4885L3MBTL1 1858/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.